Metabolomics

Dataset Information

0

1H HR-MAS NMR based metabolomics of cancer cells responding to two different doses of the diruthenium trithiolato complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)


ABSTRACT: The trithiolato bridged diruthenium complex DiRu-1 [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ is highly cytotoxic against various cancer cell lines, but its exact mode of action remained unknown. The present 1H HR-MAS NMR based metabolomic study performed on the ovarian cancer cell lines A2780, its cisPt resistant variant A2780cisR and on the healthy cell line model HEK-293 treated with two doses of DiRu-1 was designed to reveal its mode of action. The resulting changes in the metabolic profile of the cell lines were studied using HR-MAS NMR of cell lysates and subsequent statistical analysis. We show that DiRu-1 in a 0.03 µM dose has significant impact on the levels of a number of metabolites, such as glutamine, glutamate, glutathione, cysteine, lipid, creatine, lactate, and acetate, especially pronounced in the A2780cisR cell line. Overall, the metabolic changes observed suggest that redox homeostasis, the Warburg effect and the lipid metabolism are affected by DiRu-1.

INSTRUMENT(S): Nuclear Magnetic Resonance (NMR)

SUBMITTER: Hedvika Primasová 

PROVIDER: MTBLS1014 | MetaboLights | 2019-07-04

REPOSITORIES: MetaboLights

Similar Datasets

2010-12-08 | GSE25915 | GEO
2018-01-31 | MTBLS400 | MetaboLights
2014-05-02 | E-GEOD-46570 | biostudies-arrayexpress
2011-09-01 | GSE31625 | GEO
2023-08-30 | GSE236602 | GEO
2004-10-11 | GSE1823 | GEO
2019-03-07 | E-MTAB-7737 | biostudies-arrayexpress
2022-03-08 | GSE197892 | GEO
2020-06-12 | E-MTAB-8932 | biostudies-arrayexpress
2012-10-01 | E-GEOD-41255 | biostudies-arrayexpress